3.95 USD
↗ 0.68 (20.80%)AT CLOSE (03:59 PM EST)
Briacell Therapeutics Corp. Common Shares
BCTXNASDAQ • USD
3.98
↗ 0.03 (0.73%)
POST MARKET (AS OF 04:13 PM EST)
Post Market
AS OF 04:13 PM EST
3.98
↗ 0.03 (0.73%)
Market: CLOSED
Shares of Briacell Therapeutics Corp. Common Shares (BCTX) are trading at $3.95. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 6, 2026.
Open?$3.34
High?$4.08
Low?$3.30
Prev. Close?$3.27
Volume?160.5K
Avg. Volume?77.9K
VWAP?$3.79
Rel. Volume?2.06x
Bid / Ask
Bid?$3.95 × 600
Ask?$4.01 × 300
Spread?$0.06
Midpoint?$3.98
Valuation & Ratios
Market Cap?34.5M
Shares Out?8.7M
Float?8.5M
Float %?97.9%
P/E Ratio?N/A
P/B Ratio?2.10
EPS?-$4.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.
Themes
Employees
31
Market Cap
34.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-09-05
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
WEST VANCOUVER, A1 V7T 2X1
Phone: (604) 921-1810
WEST VANCOUVER, A1 V7T 2X1
Phone: (604) 921-1810
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?-10.46Distress
Confidence?44%Low
Short InterestVery High
Short % of Float?9.27%Elevated
Short Interest?789.5K
Days to Cover?14.2
Free Float8.5M
Avg Daily Volume55.4K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.76Strong
Quick Ratio?2.76Strong
Cash Ratio?1.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.10CHEAP▾
Peers100
S&P72
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-212.8%WEAK▾
S&P3
ROA?-148.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28778372
Enterprise Value?$24.6M
Fundamentals ratios updated end of day